ConductScience.org, home

Paper8554983

Oestrogen receptor: a stable phenotype in breast cancer.

Robertson JF. Br J Cancer, 1996. Cited by 123 papers, by iCite.

Cite this record

ConductScience Library. Oestrogen receptor: a stable phenotype in breast cancer. Papers, record 8554983. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8554983

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Oestrogen receptor: a stable phenotype in breast cancer.
PubMed
Journal
Br J Cancer
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
3.15
iCite
Revised in PubMed
2019-05-15
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Robertson JFJ F

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Receptors, EstrogenMajor topic
Animals
Humans
Phenotype

References98

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12606454Oestrogen receptors in benign epithelial lesions and intraduct carcinomas of the breast: an immunohistological study.Histopathology1989https://conductscience.org/library/papers/2606454PubMed
22164337Estrogen receptors in ductal carcinoma in situ of breast.Am Surg1990https://conductscience.org/library/papers/2164337PubMed
32393857Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells.Cancer Res1990https://conductscience.org/library/papers/2393857PubMed
42224859Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.Cancer Res1990https://conductscience.org/library/papers/2224859PubMed
51988075Variant human breast tumor estrogen receptor with constitutive transcriptional activity.Cancer Res1991https://conductscience.org/library/papers/1988075PubMed
6200253Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.Br J Cancer1977https://conductscience.org/library/papers/200253PubMed
7922747Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.Cancer Res1977https://conductscience.org/library/papers/922747PubMed
8631176Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer.Eur J Cancer (1965)1978https://conductscience.org/library/papers/631176PubMed
9698968Estrogen receptor assay in primary breast cancer and early recurrence of the disease.Cancer Res1978https://conductscience.org/library/papers/698968PubMed
10708575Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.Br J Cancer1978https://conductscience.org/library/papers/708575PubMed
11728342Inter-site variation of oestrogen receptors in human breast cancers.Br J Cancer1978https://conductscience.org/library/papers/728342PubMed
1286771Oestrogen receptors and prognosis in early breast cancer.Lancet1979https://conductscience.org/library/papers/86771PubMed
13476576Prognostic value of estrogen receptors in primary breast cancer.Cancer1979https://conductscience.org/library/papers/476576PubMed
147357496Changes in multiple or sequential estrogen receptor determinations in breast cancer.Cancer1980https://conductscience.org/library/papers/7357496PubMed
157358078Intratumoral variation of cytoplasmic and nuclear estrogen receptor concentrations in human mammary carcinoma.Eur J Cancer (1965)1980https://conductscience.org/library/papers/7358078PubMed
167371003Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer.Cancer Res1980https://conductscience.org/library/papers/7371003PubMed
177214366Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.Cancer Res1981https://conductscience.org/library/papers/7214366PubMed
187226005Estrogen receptor: a prognostic factor in breast cancer.Cancer1981https://conductscience.org/library/papers/7226005PubMed
197235760Sampling procedures in estrogen receptor determinations.Ann Surg1981https://conductscience.org/library/papers/7235760PubMed
207272932Clinical pharmacology of tamoxifen in patients with breast cancer: correlation with clinical data.Cancer1981https://conductscience.org/library/papers/7272932PubMed

See all 98 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
38281118Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions.Integr Cancer Ther2024https://conductscience.org/library/papers/38281118PubMed
30659843Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer.Mol Cell Endocrinol2019https://conductscience.org/library/papers/30659843PubMed
25925673Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.J Transl Med2015https://conductscience.org/library/papers/25925673PubMed
24758408Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferation.BMC Cancer2014https://conductscience.org/library/papers/24758408PubMed
24449872Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24449872PubMed
21903739Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.J Nucl Med2011https://conductscience.org/library/papers/21903739PubMed
21447808Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.J Natl Cancer Inst2011https://conductscience.org/library/papers/21447808PubMed
20496165Comprehensive screen of genetic variation in DNA repair pathway genes and postmenopausal breast cancer risk.Breast Cancer Res Treat2011https://conductscience.org/library/papers/20496165PubMed
20473330Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.Oncogene2010https://conductscience.org/library/papers/20473330PubMed
19372579Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.Mol Cancer Res2009https://conductscience.org/library/papers/19372579PubMed
17912640Femara and the future: tailoring treatment and combination therapies with Femara.Breast Cancer Res Treat2007https://conductscience.org/library/papers/17912640PubMed
17804714Genetic screening reveals an essential role of p27kip1 in restriction of breast cancer progression.Cancer Res2007https://conductscience.org/library/papers/17804714PubMed
17486454Growth factor signalling in endocrine and anti-growth factor resistant breast cancer.Rev Endocr Metab Disord2007https://conductscience.org/library/papers/17486454PubMed
17160137The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer.J Clin Invest2007https://conductscience.org/library/papers/17160137PubMed
15642172
Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
Breast Cancer Res2005https://conductscience.org/library/papers/15642172PubMed
15536519Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.J Mol Med (Berl)2005https://conductscience.org/library/papers/15536519PubMed
14973389Estrogen receptor alpha in human breast cancer: occurrence and significance.J Mammary Gland Biol Neoplasia2000https://conductscience.org/library/papers/14973389PubMed
12118371Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.Oncogene2002https://conductscience.org/library/papers/12118371PubMed
12096339Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.Oncogene2002https://conductscience.org/library/papers/12096339PubMed
12013530The role of estrogen receptors in breast cancer metastasis.J Mammary Gland Biol Neoplasia2001https://conductscience.org/library/papers/12013530PubMed

See all 28 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8554983

GET https://conductscience.org/api/papers/v1/8554983/references?page=2